Synthesis of pyrimidine analog of fluoroneplanocin A as potential anti-HCV agent.

Nucleic Acids Symp Ser (Oxf)

College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 609-735, Korea.

Published: November 2010

AI Article Synopsis

  • N-hydroxycytosine nucleoside 3 was created as a potential treatment for Hepatitis C Virus (HCV).
  • The synthesis process began with D-ribose and involved several key reactions, including an iodine-fluorine exchange, RCM reaction, stereoselective reduction, and Mitsunobu reaction.
  • BuLi (butyllithium) was utilized as a crucial reagent in the synthesis steps.

Article Abstract

N-hydroxycytosine nucleoside 3 was synthesized as potential anti-HCV agent, starting from D-ribose using an iodine-fluorine exchange reaction by a help of BuLi, a RCM reaction, a stereoselective reduction and a Mitsunobu reaction as the key steps.

Download full-text PDF

Source
http://dx.doi.org/10.1093/nass/nrn307DOI Listing

Publication Analysis

Top Keywords

potential anti-hcv
8
anti-hcv agent
8
synthesis pyrimidine
4
pyrimidine analog
4
analog fluoroneplanocin
4
fluoroneplanocin potential
4
agent n-hydroxycytosine
4
n-hydroxycytosine nucleoside
4
nucleoside synthesized
4
synthesized potential
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!